Phase III trial of cisplatin/gemcitabine with or without vinorelbine or paclitaxel in advanced non-small cell lung cancer

Seminars in Oncology

Volumn 28, Issue 2 SUPPL. 7, 2001, Pages 7-10

  Comella, Pasquale ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; GEMCITABINE; NAVELBINE; PACLITAXEL;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; FATIGUE; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; NEUROPATHY; PERFORMANCE; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE; THROMBOCYTOPENIA; TREATMENT OUTCOME; VOMITING;

EID: 0035020048     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/sonc.2001.24366     Document Type: Article

References (13)

1. AJ Wozniak JJ Crowley SP Balcezark Randomized trial comparing cisplatin with cisplatin plus vinorelbine in the treatment of advanced non-small cell lung cancer (NSCLC): A Southwest Oncology Group study J Clin Oncol 16 1998 2459 2465
2. AB Sandler J Nemunaitis C Denham Phase III trial of gemcitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic non-small-cell lung cancer J Clin Oncol 18 2000 122 130
3. L Crinò GV Scagliotti S Ricci Gemcitabine and cisplatin versus mitomycin, ifosfamide, and cisplatin in advanced non-small-cell lung cancer: A randomized phase III study of the Italian Lung Cancer Project J Clin Oncol 17 1999 3522 3530
4. G Giaccone TA Splinter C Debruyne Randomized study of paclitaxel-cisplatin versus cisplatin-teniposide in patients with advanced non-small-cell lung cancer. The European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group J Clin Oncol 16 1998 2133 2141
5. P Bonomi K Kim D Fairclough Comparison of survival and quality of life in advanced non-small-cell lung cancer patients treated with two dose levels of paclitaxel combined with cisplatin versus etoposide with cisplatin. Results of an Eastern Cooperative Oncology Group Trial J Clin Oncol 18 2000 623 631
6. S Niho K Nagao Y Nishiwaki Randomized multicenter phase III trial of irinotecan (CPT-11) and cisplatin (CDDP) versus CDDP and vindesine (VND) in patients with advanced non-small cell lung cancer (NSCLC) Proc Am Soc Clin Oncol 18 1999 492a (abstr 1897)
7. N Masuda M Fukuoka S Negoro Randomized trial comparing cisplatin (CDDP) and irinotecan (CPT-11) versus CDDP and vindesine (VDS) versus CPT-11 alone in advanced non-small cell lung cancer (NSCLC). A multicenter phase III study Proc Am Soc Clin Oncol 18 1999 459a (abstr 1774)
8. J von Pawel R von Roemeling U Gatzemeier Tirapazamine plus cisplatin versus cisplatin in advanced non-small cell lung cancer: A report of the International CATAPULT I study group J Clin Oncol 18 2000 1351 1359
9. JH Schiller D Harrington A Sandler A randomized phase III trial of four chemotherapy regimens in advanced non-small cell lung cancer (NSCLC) Proc Am Soc Clin Oncol 19 2000 1a (abstr 2)
10. P Comella G Frasci N Panza Cisplatin-gemcitabine-vinorelbine combination in advanced non-small cell lung cancer. A phase II randomized study of the Southern Italy Cooperative Oncology Group J Clin Oncol 17 1999 1526 1534
11. G Frasci N Panza P Comella Cisplatin, gemcitabine and paclitaxel in locally advanced or metastatic non-small cell lung cancer: A phase I–II study J Clin Oncol 17 1999 2316 2325
12. P Comella G Frasci N Panza Randomized trial comparing cisplatin, gemcitabine, and vinorelbine with either cisplatin and gemcitabine or cisplatin and vinorelbine in advanced non-small-cell lung cancer. Interim analysis of a phase III trial of the Southern Italy Cooperative Oncology Group J Clin Oncol 18 2000 1451 1457
13. P Comella Triple- vs. double-agent chemotherapy for advanced non-small-cell lung cancer: Interim analysis of a phase HI trial Oncology 14 suppl 4 2000 35 40